Abeona Therapeutics Inc.ABEONASDAQ
Loading
ABEO Revenue Growth (YoY Quarterly)•+0.00%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+29.00%
+16.2pp
+61.12%
+48.3pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +1275.86% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +1369.52% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +989.47% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +1121.43% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +60.62% | +82.23% | +31.28% | +12.81% | +29.00% |
| Weighted Average Shares Diluted Growth | +60.62% | +82.23% | +30.09% | +12.81% | +61.12% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -32.41% | -27.55% | -0.61% | +0.19% | +306.48% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +70.20% | +32.79% | +83.75% | +91.63% | +101.57% |
| Book Value per Share Growth | +84.90% | +0.00% | +70.13% | +231.60% | +180.30% |
| Debt Growth | +326.81% | +3.49% | +3.93% | +4.32% | +8.33% |
| R&D Expense Growth | +21.89% | +37.94% | -35.53% | -52.85% | -25.37% |
| SG&A Expenses Growth | +35.09% | +37.39% | +98.35% | +201.59% | +172.12% |
1 / 4